期刊文献+

肥胖伴非酒精性脂肪肝病患儿血管内皮功能的变化研究 被引量:4

Change of Vascular Endothelial Function in Obese Children with Non-alcoholic Fatty Liver Disease
下载PDF
导出
摘要 目的探讨肥胖患儿非酒精性脂肪肝病(NAFLD)与血管内皮功能障碍的关系。方法 90例肥胖患儿以及34例非肥胖儿童(对照组)进行临床、生化指标及肱动脉血流介导的内皮依赖性舒张功能(FMD)各项检查,根据诊断标准将90例肥胖患儿分为NAFLD组51例和单纯肥胖组39例。比较各组儿童临床、生化各项指标及FMD。结果 NAFLD病组患儿FMD为(7.9±2.1)%,低于单纯肥胖组(10.6±1.7)%和对照组(12.1±2.1)%,三组间差异有统计学意义(F=8.32,P<0.05);NAFLD组患儿内皮素-1、超敏C反应蛋白(hs-CRP)、胰岛素抵抗指数(HOMA-IR)、可溶性细胞间黏附分子-1水平均高于单纯肥胖组和对照组,三组间差异有统计学意义(P<0.05)。经逐步线性回归分析显示,FMD水平和hs-CRP、HOMA-IR、NAFLD呈负相关(r值分别为-0.487、-0.424、-0.407,P<0.05)。结论肥胖患儿NAFLD的出现不仅是血管内皮功能障碍发生的早期标志,也是血管内皮功能障碍发生的早期状态。 Objective To study the relationship between non - alcoholic fatty liver disease (NAFLD) and the vascular endothelial dysfunction in children with obesity. Methods A total of 90 obese children and 34 non - obese children as control were enrolled. Their clinical indicators, biochemical indicators, and flow - mediated dilatation (FMD) of braehial artery were examined. The obese children were classified into two subgroups according to the diagnosis criteria: obesity group without liver disorder (n = 39 ) and NAFLD group (n = 51 ). The clinical indicators, biochemical indicators, and FMD of braehial artery were compared among the three groups. Results The FMD prevalence in NAFLD group was (7.9 ± 2. 1 ) % , lower than ( 10. 6 ± 1.7 ) % in obesity group and ( 12.1 ± 2. 1 ) % in control group, with a significant difference among the 3 groups ( F = 8.32, P 〈0. 05 ). The levels of endothelin - 1 ( ET - 1 ), high sensitivity C - reactive protein ( hs - CRP), HOMA insulin resistance index (HOMA- IR) and soluble intercellular adhesion molecule (slCAM -1 ) in NAFLD were all higher than those in obesity and control groups, with a significant difference among the 3 groups ( P 〈 0. 05 ). The liner stepwise regression analysis showed that the FMD was negatively correlated with hs - CRP, HOMA - IR and NAFLD (r = - 0. 487, - 0. 424, - 0. 407, P 〈 0. 05 ). Conclusion NAFLD may be not only an early marker but also an early state of vascular endothelial dysfunction in obese children.
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第34期3978-3980,共3页 Chinese General Practice
关键词 非酒精性脂肪肝 内皮功能障碍 肥胖 炎症 儿童 Non - alcoholic fatty liver disease Endothelial dysfunction Obesity Inflammation Child
  • 相关文献

参考文献14

  • 1Schwimrner JB, Behling C, Newbury R, et al. Histopathology of pediat- ric non - alcoholic fatty liver disease [ J ]. Hepatology, 2005, 42 (3) : 641 -649.
  • 2Pacifico L, Cantisani V, Rieci P, et al. Nonalcoholic fatty liver disease and carotid atherosclemsis in children [ J ]. eediatr Res, 2008, 63 (4) : 423 - 427.
  • 3乔华,何胜虎.血管内皮细胞功能检测方法及意义[J].实用心脑肺血管病杂志,2010,18(4):531-533. 被引量:12
  • 4非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].中华肝脏病杂志,2010,18(3):163-166. 被引量:1161
  • 5Guangda X, Linshuang Z, Jie H, et al. Apo e4 allele is associated with endothelium -dependent arterial dilation in women with type 2 diabetes [J]. Diabetes Res Clin Praet, 2006, 72 (2) : 155 - 161.
  • 6Roberts EA. Pediatric non - alcoholic fatty liver disease (NAFLD) : A " growing"problem? [J]. J Hepatol, 2007, 46 (6): 1133-1142.
  • 7Schwimmer JB, Pardee PE, Lavine JE, et al. Cardiovascular risk fac- tors and the metabolic syndrome in pediatric nonalcoholic fatty liver dis- ease [J]. Circulation, 2008, 118 (3): 277-283.
  • 8Tounian P, Aggoun Y, Dubern B, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: A prospective study [ J ]. Lancet, 2001, 358 (9291) : 1400 - 1404.
  • 9Djuric D, Popovic Z, Petrovic J, et al. Age - related progressive bra- chial artery endothelial dysfunction precedes the changed carotid and left ventricular geometry in healthy humans [ J ]. Angiology, 1999, 50 (7) : 555 -561.
  • 10Piro S, Spampinato D, Spadaro L, et al. Direct apoptotic effects of free fatty acids on human endothelial cells [ J ]. Nutr Metab Cardio- vasc Dis, 2008, 18 (2): 96-104.

二级参考文献7

共引文献1171

同被引文献45

  • 1Trauner M,Arrese M,Wagner M.Fatty liver and lipotox-icity[J].Biochim Biophys Acta,2010,1801(3):299.
  • 2中国人民解放军总后勤部卫生部.《临床疾病诊断依据治愈好转标准》(第2版)[M].人民军医出版社,1987:116.
  • 3Reynaert H,Thompson MG,Thomas T,et al.Hepatic stellate cells:role in microcirculation and pathophysiology of portal hypertension[J].Gut,2002,50(4):571-581.
  • 4Haukeland JW, Damas JK, Konopski Z, et al. Systemicinflammation in nonalcoholic fatty liver disease is characterizedby elevated levels of CCL2 [J]. J Hepatol, 2006, 44 ( 6 ) : 1167-1174.
  • 5Sciacqua A, Perticone M, Miceli S, et al. Endothelialdysfunction and non-alcoholic liver steatosis in hypertensivepatients[J]. Nutr Metab Cardiovasc Dis,2011,21(7) :485-491.
  • 6Roitberg GE, Sharkhun OO, Ushakova TI. Non-alcoholic fattyliver disease as an atherosclerosis risk factor [J]. Eksp KlinGastroenterol,2010,7(7) :20-24.
  • 7Bonetti PO, Lerman LO,Lerman A. Endothelial dysfunction: amarker of atherosclerotic risk [ J]. Arterioscler Thromb VaseBiol,2003,23(2) :168-175.
  • 8Guangda X,Linshuang Z, Jie H, et al. Apo e4 allele isassociated with endothelium-dependent arterial dilation in womenwith type 2 diabetes[J]. Diabetes Res Clin Pract, 2006 * 72(2):155-161.
  • 9Piro S, Spampinato D, Spadaro L,et al. Direct apoptotic effectsof free fatty acids on human endothelial cells[J]. Nutr MetabCardiovasc Dis,2008,18(2) ;96-104.
  • 10Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liverdisease: pathology and pathogenesis [ J]. Annu Rev Pathol.2010,5(1):145-171.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部